# Craniometrix **Source:** https://geo.sig.ai/brands/craniometrix **Vertical:** Healthcare **Subcategory:** General **Tier:** Emerging **Website:** craniometrix.com **Last Updated:** 2026-04-14 ## Summary SF dementia care coordination platform with Johns Hopkins MIND at Home partnership; YC $6.5M with $1.9M revenue connecting patients and caregivers through virtual care navigation for Alzheimer's management. ## Company Overview Craniometrix is a San Francisco-based digital health company providing virtual dementia care coordination — connecting dementia patients, family caregivers, and healthcare providers through a telemedicine platform that delivers cognitive assessment, care planning, caregiver education, and ongoing care management for Alzheimer's and related dementia conditions. Founded by CEO Nikhil Patel and backed by Y Combinator with $6-6.5 million raised from Y Combinator, Quiet Capital, and Defy.vc, Craniometrix generated $1.9 million in revenue in 2024 and partners with the Johns Hopkins MIND at Home program — a validated community-based dementia care model developed by Johns Hopkins University School of Medicine. Craniometrix's care coordination platform addresses the fragmentation of dementia care support: most families managing a dementia diagnosis navigate neurologist appointments, primary care coordination, caregiver burnout, legal planning (power of attorney, advance directives), safety modifications (home monitoring, medication management), and community support resources without a guide — each element requires separate research and provider coordination. Craniometrix's platform provides a unified care navigator relationship that coordinates across these domains: digital cognitive assessments (Craniometrix administers validated cognitive screening tools remotely), care plan development, caregiver coaching on behavioral symptoms, and referrals to vetted local dementia support resources and clinical trials. In 2025, Craniometrix competes in the digital dementia care market with DementiaMap (care navigation platform), Dementia Care Specialists (trained care advisor model), and telehealth platforms (Teladoc TDOC, Brightside Health) expanding into geriatric and cognitive care for dementia family support services. The dementia care market is structurally underserved — 6.7 million Americans living with Alzheimer's in 2023 creates a massive caregiver support need that traditional healthcare systems provide inadequately. Johns Hopkins MIND at Home validation provides clinical credibility for Craniometrix's care model. Y Combinator backing connects Craniometrix with the digital health and elder care technology investor community. The 2025 strategy focuses on health plan partnerships (Medicare Advantage plans with CHRONIC Care Act chronic care management billing), employer benefit channels (employees managing parent dementia care), and growing the behavioral symptom management coaching that reduces caregiver burnout and emergency utilization. ## Frequently Asked Questions ### What is Craniometrix? Craniometrix is a telemedicine platform founded in 2021 that provides virtual non-clinical support for dementia patients and their families. The company partners with Johns Hopkins MIND at Home program to build a comprehensive one-stop-shop Alzheimer's care platform. ### What products and services does Craniometrix offer? Craniometrix offers virtual dementia support, Johns Hopkins partnership care, non-clinical patient assistance, family caregiver resources, and Alzheimer's telemedicine. The platform provides dementia care management, patient/family coordination, and comprehensive Alzheimer's support services. ### Who is Craniometrix designed for? Craniometrix serves dementia patients, family caregivers, healthcare providers, and Alzheimer's families requiring accessible care coordination. The platform is designed for those seeking comprehensive support and resources for managing dementia and Alzheimer's care. ### When was Craniometrix founded? Craniometrix was founded in 2021 and participated in Y Combinator's W22 batch. ### Where is Craniometrix located? Craniometrix is based in the United States. ### How much funding has Craniometrix raised? Craniometrix has raised $6M-$6.5M in total funding, including a seed round in March 2022. Investors include Quiet Capital, Defy.vc, Olive Tree Capital, Rebel Fund, J Ventures, Cathexis Ventures, and Y Combinator. ### What are Craniometrix's key achievements and metrics? Craniometrix achieved $1.9M in revenue in 2024 and has grown to an 11-person team. The company has established a strategic partnership with Johns Hopkins MIND at Home program. ### What is Craniometrix's approach to dementia care? Craniometrix uses a telemedicine and digital diagnostics approach to provide virtual non-clinical support for dementia patients. The company focuses on building a comprehensive, accessible one-stop-shop platform for Alzheimer's care coordination. ### Who founded Craniometrix? Craniometrix was founded by CEO Nikhil Patel, who is a published author on digital diagnostics for Alzheimer's disease. ### What recent developments has Craniometrix announced? Recent developments include achieving $1.9M in revenue in 2024, securing $6M-$6.5M in total funding, and establishing a partnership with Johns Hopkins MIND at Home program. The company has grown to 11 employees while expanding its one-stop-shop Alzheimer's care platform. ## Tags healthtech, saas, analytics, north-america, b2b --- *Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*